Latest Stories
American Airlines (NASDAQ:AAL) Posts Q1 Sales In Line With Estimates
Global airline American Airlines (NASDAQ:AAL) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $12.55 billion. Its non-GAAP loss of $0.59 per share was 12.1% above analysts’ consensus estimates.
Merck’s (NYSE:MRK) Q1 Sales Beat Estimates
Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.
FAST Q1 Earnings Call: Management Addresses Tariffs, Supply Chain, and Digital Strategy
Industrial supplier Fastenal (NASDAQ:FAST) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $1.96 billion. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.
UAL Q1 Earnings Call: Brand Loyalty and Capacity Adjustments Drive Outperformance in Uncertain Market
Airline company United Airlines Holdings (NASDAQ:UAL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.4% year on year to $13.21 billion. Its non-GAAP profit of $0.91 per share was 23.8% above analysts’ consensus estimates.
BMI Q1 Earnings Call: Margin Expansion Driven by Mix, Tariff Uncertainty Remains
Water control and measure company Badger Meter (NYSE:BMI) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 13.2% year on year to $222.2 million. Its non-GAAP profit of $1.30 per share was 23.1% above analysts’ consensus estimates.
Graco (NYSE:GGG) Reports Q1 In Line With Expectations
Fluid and coating equipment company Graco (NYSE:GGG) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.3% year on year to $528.3 million. Its non-GAAP profit of $0.70 per share was 3.9% above analysts’ consensus estimates.
TMO Q1 Earnings Call: Navigating Tariffs and Macro Uncertainty While Investing in Innovation
Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15 per share was 0.9% above analysts’ consensus estimates. The stock remained flat at $433.50 following the earnings release and call.
Penumbra’s (NYSE:PEN) Q1 Sales Beat Estimates, Stock Soars
Medical device company Penumbra (NYSE:PEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 16.3% year on year to $324.1 million. The company expects the full year’s revenue to be around $1.35 billion, close to analysts’ estimates. Its non-GAAP profit of $0.83 per share was 24.4% above analysts’ consensus estimates.
Knight-Swift Transportation (NYSE:KNX) Posts Better-Than-Expected Sales In Q1
Freight delivery company Knight-Swift Transportation (NYSE:KNX) beat Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $1.82 billion. Its non-GAAP profit of $0.28 per share was 18.7% above analysts’ consensus estimates.
IMAX’s (NYSE:IMAX) Q1: Beats On Revenue
Premium cinema technology company IMAX (NYSE:IMAX) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $86.67 million. Its GAAP profit of $0.04 per share was $0.01 below analysts’ consensus estimates.